Summary:
- This article discusses the contribution of scientists from the Medicines and Healthcare products Regulatory Agency (MHRA) in the UK to an international study on the stability of a novel oral polio vaccine.
- The study aimed to evaluate the stability and potency of the novel oral polio vaccine, which is an important tool in the global effort to eradicate polio.
- The MHRA scientists provided their expertise in analytical testing and stability assessment, helping to ensure the vaccine meets the necessary quality and safety standards for use in polio eradication programs worldwide.